康泰生物
(300601)
| 流通市值：123.93亿 | | | 总市值：156.26亿 |
| 流通股本：8.86亿 | | | 总股本：11.17亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 219,937,690.38 | 432,840,378.47 | 190,632,300.7 | 323,144,611.76 |
| 应收票据及应收账款 | 2,863,081,707.32 | 2,787,045,936.42 | 2,878,860,051.21 | 2,802,996,728.95 |
| 其中：应收票据 | 8,817,001.01 | - | 49,545 | - |
| 应收账款 | 2,854,264,706.31 | 2,787,045,936.42 | 2,878,810,506.21 | 2,802,996,728.95 |
| 应收款项融资 | - | 0 | 0 | 0 |
| 预付款项 | 24,177,808.47 | 26,578,453.93 | 29,731,844.17 | 30,786,381.21 |
| 其他应收款合计 | 8,580,322.35 | 10,536,156.67 | 8,719,019.78 | 8,467,685.01 |
| 存货 | 726,163,704.93 | 782,767,957.21 | 868,334,750.87 | 894,840,348.36 |
| 其他流动资产 | 2,387,591,312 | 2,202,520,055.69 | 1,754,266,199.01 | 459,107,487.47 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 6,229,532,545.45 | 6,242,288,938.39 | 5,850,624,265.74 | 4,519,343,242.76 |
| 非流动资产: | | | | |
| 投资性房地产 | 783,356,053.57 | 787,547,166.28 | 489,733,719.06 | 494,915,534.04 |
| 固定资产 | 4,193,402,763.11 | 4,235,306,504.99 | 4,321,958,518.78 | 4,188,935,211.19 |
| 在建工程 | 962,817,334.98 | 990,283,518.03 | 1,311,496,175.49 | 1,478,247,083.05 |
| 无形资产 | 427,583,964.18 | 436,663,032.83 | 445,751,601.51 | 452,969,916.39 |
| 开发支出 | 115,849,555.45 | 97,794,434.53 | 81,086,019.24 | 51,878,743.89 |
| 长期待摊费用 | 159,226,115.56 | 170,461,150.91 | 75,555,755.03 | 84,179,616.53 |
| 递延所得税资产 | 693,042,229.68 | 697,626,350.41 | 643,572,146.18 | 657,140,703.73 |
| 其他非流动资产 | 690,117,086.56 | 905,743,398.96 | 1,295,761,513.46 | 2,517,845,804.62 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 8,025,395,103.09 | 8,321,425,556.94 | 8,664,915,448.75 | 9,926,112,613.44 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 14,254,927,648.54 | 14,563,714,495.33 | 14,515,539,714.49 | 14,445,455,856.2 |
| 流动负债: | | | | |
| 短期借款 | 35,606,312.5 | 34,102,910.54 | 155,678,905.79 | 158,600,438.82 |
| 应付票据及应付账款 | 709,837,080.52 | 847,825,622.04 | 789,032,555.1 | 794,781,234.34 |
| 其中：应付票据 | 152,362,517.69 | 186,780,333.79 | 162,189,348.62 | 98,349,733.25 |
| 应付账款 | 557,474,562.83 | 661,045,288.25 | 626,843,206.48 | 696,431,501.09 |
| 预收款项 | 733,285.43 | 858,863.08 | 2,180,627.74 | 2,992,124.84 |
| 合同负债 | 19,347,470.26 | 18,421,267.86 | 21,646,679.08 | 18,117,222.52 |
| 应付职工薪酬 | 39,662,035.18 | 58,882,396.1 | 32,619,203.3 | 32,836,781.21 |
| 应交税费 | 14,580,910.1 | 22,289,407.63 | 17,692,827.13 | 18,945,145.18 |
| 其他应付款合计 | 1,395,966,085 | 1,461,258,486.9 | 1,488,856,324.15 | 1,536,949,743.65 |
| 一年内到期的非流动负债 | 111,168,017.6 | 202,954,572.59 | 110,446,791.18 | 128,560,670.32 |
| 其他流动负债 | 585,017.04 | 552,638.05 | 618,702.36 | 507,553.19 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 2,327,486,213.63 | 2,647,146,164.79 | 2,618,772,615.83 | 2,692,290,914.07 |
| 非流动负债: | | | | |
| 长期借款 | - | 0 | 85,000,000 | 85,000,000 |
| 应付债券 | 1,807,229,504.05 | 1,786,479,371.34 | 1,765,533,392.42 | 1,745,431,262.42 |
| 预计负债 | 151,281,291.43 | 186,717,135.91 | 30,151,967.72 | 76,492,734.6 |
| 递延收益 | 251,052,687.98 | 247,824,792.28 | 281,656,436.93 | 286,577,312.49 |
| 递延所得税负债 | 34,483,765.22 | 34,521,682 | 24,937,092.21 | 24,975,008.99 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 2,244,047,248.68 | 2,255,542,981.53 | 2,187,278,889.28 | 2,218,476,318.5 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 4,571,533,462.31 | 4,902,689,146.32 | 4,806,051,505.11 | 4,910,767,232.57 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,116,927,887 | 1,116,927,737 | 1,116,916,739 | 1,116,916,689 |
| 其他权益工具 | 511,044,650.24 | 511,045,417.19 | 511,101,148.51 | 511,101,404.16 |
| 资本公积 | 5,510,766,852.12 | 5,510,725,626.71 | 5,409,668,507.43 | 5,420,509,145.82 |
| 其他综合收益 | -147,820.98 | -90,939.67 | -137,744.56 | -54,412.97 |
| 盈余公积 | 347,128,374.64 | 347,128,374.64 | 327,558,677.67 | 327,558,677.67 |
| 未分配利润 | 2,197,821,795.31 | 2,175,387,706.75 | 2,344,400,715.39 | 2,158,641,452.6 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 9,683,541,738.33 | 9,661,123,922.62 | 9,709,508,043.44 | 9,534,672,956.28 |
| 少数股东权益 | -147,552.1 | -98,573.61 | -19,834.06 | 15,667.35 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 9,683,394,186.23 | 9,661,025,349.01 | 9,709,488,209.38 | 9,534,688,623.63 |
| 负债和股东权益合计 | 14,254,927,648.54 | 14,563,714,495.33 | 14,515,539,714.49 | 14,445,455,856.2 |
| 公告日期 | 2025-04-21 | 2025-04-21 | 2024-10-26 | 2024-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |